Transplant Diagnostics Market Size, Scope, Growth, Competitive Analysis 2022

According to Precision Business Insights (PBI), the latest report, the transplant diagnostics market size was valued at USD 4.1 billion in 2021, growing at a 7.8% CAGR from 2022 to 2028. With a rise in the prevalence of chronic diseases that might cause organ failure, it is anticipated that the use of transplant diagnostics (including pre-and post-transplant screening) will increase significantly. Due to the multiple advantages these tests offer to determine the organ transplant procedure's viability, and the market has attracted the attention of healthcare practitioners. The management of organ transplants now has access to enhanced diagnostic alternatives due to major technological breakthroughs in transplant diagnostics. The market is mature in industrialized nations. However, there are prospective markets for transplant diagnostics in developing countries like LAMEA and Asia-Pacific.

View the detailed report description here - https://precisionbusinessinsights.com/market-reports/transplant-diagnostics-market/

Software and Services Segment to Dominate the Transplant Diagnostics Market:
The software and services segment are expected to account for a larger revenue share in the global transplant diagnostics market, with a value share worldwide. It is projected to grow at a 7.9% CAGR between 2022 and 2028. The introduction of more complex instruments has raised the need for training sessions to instruct technical employees on handling and usage, which has contributed to the expansion of this market. Additionally, the industry growth is fueled by regular software upgrades and better services provided by market competitors to remain competitive.

North America Transplant Diagnostics Market:
The North America market is expected to increase in the global transplant diagnostics market over the forecast period. It is projected to grow at a CAGR of 8.2% in the coming years. Countries like the United States and Canada are well-equipped with the infrastructure, sponsored organizations, and government involvement needed to raise money and awareness to support patient organ transplantation. For instance, in June 2021, the National Institute of Health reported that the funding for transplantation research in 2018, 2019, and 2020 was USD 650 million, USD 733 million, and USD 721 million, respectively. Increasing use of transplant diagnostics will thus result from increased financing for transplantation research, fueling the expansion of this market.

Request sample report at https://precisionbusinessinsights.com/request-sample?product_id=46377

Strategic New Product Launches, Mergers, Acquisitions, and Agreements are the key strategies adopted by market players:
The global transplant diagnostics market further reveals that the key players are increasingly adopting strategies such as the launch of newer products, product launches, and long-term alliances to improve market revenue share and gain significant geographic presence across the region. For instance, In February 2022, Bio-Techne Corporation, a US-based supplier of medical and life science research tools, announced its agreement with Thermo Fisher Scientific for complete development and commercialization of the ExoTRU Kidney Transplant Rejection Test.

Detailed Segmentation:
The transplant diagnostics market is segmented based on technology, product & service, transplant type, application, end user, and geography.
Based on the technology, the market is segmented into the following:
• Molecular Assay Technologies
• Non-molecular Assay Technologies

Based on the product & service, the market is segmented into the following:
• Reagents & Consumables
• Instruments
• Software & Services

Based on the transplant type, the market is segmented into the following:
• Solid Organ Transplantation
• Stem Cell Transplantation
• Soft Tissue Transplantation
• Bone marrow Transplantation

Based on the application, the market is segmented into the following:
• Diagnostic Applications
• Research Applications

Based on the end user, the market is segmented into the following:
• Independent Reference Laboratories
• Hospitals & Transplant Centers
• Research Laboratories & Academic Institutes

Request Methodology: https://precisionbusinessinsights.com/request-methodology?product_id=46377

Key players' profiles in the Transplant Diagnostics market report Abbott Laboratories Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche, Ltd., Illumina, Inc., Immucor, Inc., Linkage Biosciences, Olerup Ssp Ab, Qiagen N.V., Thermo Fisher Scientific Inc., and Sigma-Aldrich.

Contact:
Mr. Satya
Precision Business InsightsTM | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 - 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.